Changshan Pharmaceutical announced on September 15 that the company's drug heparin sodium injection has obtained a drug registration certificate issued by the Moldovan Drug Administration. This time, heparin sodium injection has obtained Moldovan registration approval, which has had a positive impact on the company's expansion into overseas markets. Currently, the company's overseas sales revenue for heparin formulation products accounts for a low proportion of the company's total revenue.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.